Avrion Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has Avrion Therapeutics raised to date?

Avrion Therapeutics has raised obfuscated.

Overview

Avrion Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Avrion Therapeutics

CB Rank

120121

Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.

Founded

obfuscation

Private

Seed

Allschwil, Basel-Landschaft, Switzerland

1-10

www.avriontx.com/

Biotechnology

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Key People

Brian McCabe: Co-founder and Chairperson of Advisory Board

Details

Legal Name

Avrion Therapeutics SA

Operating Status

Active

Company Type

For Profit

About the Company

Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AVR-001

A gene therapy product targeting ALS, specifically forms linked to SOD1 aberrations, preparing for IND-enabling studies.

Precision Gene Therapy Platform

Targets genetically-linked neurological disorders by delivering gene sequences to specific cells in the central nervous system, enhancing therapeutic efficacy and safety.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Avrion Therapeutics	—	obfuscated obfuscation	—	Seed